医疗健康活跃度持续，伯汇生物获近亿元融资｜21私募投融资

Core Insights - The financing market is dominated by the technology and manufacturing, as well as healthcare sectors, showcasing a dual advantage in case density and funding volume [1] - In the past week, over 20 financing cases were reported in the technology and manufacturing sectors, with multiple transactions exceeding 500 million RMB [1] - The healthcare sector is also actively engaging in financing, with significant transactions and innovative sub-sectors receiving capital [1] Technology and Manufacturing - Semiconductor equipment company Xinshi Nuo completed over 500 million RMB in A+ round financing [1] - Communication equipment developer Fangqing Technology secured over 500 million RMB in Pre-A round financing [1] - Satellite communication company Xinglian Xintong completed over 100 million RMB in B round financing [1] - Intelligent special robot company Boqing Technology received several hundred million RMB in B round financing [1] - Two-dimensional semiconductor company Yuanjiwei completed nearly 100 million RMB in angel round financing [1] Healthcare - New drug research service platform Kangyuan Bochuang completed 250 million RMB in B round financing [1] - Innovative drug development company Bohui Bio secured nearly 100 million RMB in A+ round financing [1] - AI-driven new drug development company Zheyuan Technology completed over 100 million RMB in A+ round financing [1] - Brain-computer interface company Jieti Medical, digital therapy company Jishi Technology, and innovative peptide drug developer Chengdu Peide Bio also received capital support [1] Regional Financing Activity - The financing activities were primarily concentrated in Jiangsu Province, Beijing, and Guangdong Province, with 7, 6, and 5 cases respectively [3] Active Investment Institutions - Yizhuang Guotou and Guoke Investment were notably active, each disclosing 2 investments primarily in the technology and manufacturing, as well as healthcare sectors [4] Notable Financing Cases - Bohui Bio completed nearly 100 million RMB in A+ round financing led by Yizhuang Guotou [5] - Jishi Technology completed A round financing led by Fengyu Capital [7] - Suzhou Baifu Laser completed over 100 million RMB in C round financing [8] - Kangyuan Bochuang completed 250 million RMB in B round financing led by Boyuan Capital [9] - All-in-One Medical Technology completed several million RMB in B+ round financing [10] - Zheyuan Technology completed over 100 million RMB in A+ round financing [11] - Dingkang Bio completed A++ round financing [12] - Jieti Medical completed B+ round financing [13] - Chengdu Peide Bio completed several million RMB in A round financing [15] - Xinglian Xintong completed over 100 million RMB in B round financing [16] - Xinshi Nuo completed over 500 million RMB in A+ round financing [17] - Fangqing Technology completed over 500 million RMB in Pre-A round financing [19] - Shenzhen Haodian Technology completed over 100 million RMB in B round financing [20] - Suzhou Junji Gene completed nearly 100 million RMB in A round financing [20] - Jiangxi Panmeng Semiconductor completed over 100 million RMB in A+ round financing [37] - White Rhino Autonomous Driving completed B++ round financing [38] - Yuanjiwei announced nearly 100 million RMB in angel round financing [39] - Yufeng Future received a new round of financing exceeding 100 million RMB [40] - Shanghai Moudian Intelligent completed several million RMB in angel round financing [41]